Clinical Trial Update: Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial studying the combination of irinotecan and capecitabine for metastatic colorectal cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Colorectal Neoplasms, Secondary | Phase 2 | Status: TERMINATED